US FDA ( Food and Drug Administration) mise à jour des indications sur le risque de suicide dans les essais cliniques - Aout 2012
Guidance for Industry Suicidal Ideation and Behavior: Prospective Assessment of Occurrence in Clinical Trials DRAFT U.S. Department of Health and Human Services Food and Drug Administration
Center for Drug Evaluation and Research (CDER) August 2012 Clinical/Medical
Revision 1
http://www.fda.gov/downloads/Drugs/.../Guidances/UCM225130.pdf
